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Abstract.  The DNA sequence between position  +36 
and  -1907 of the murine myelin basic protein gene 
contains the enhancer and promoter elements neces- 
sary for abundant and cell specific expression in trans- 
genic mice.  Surprisingly,  the pattern of expression 
promoted by this DNA fragment is a  subset of that ex- 
hibited by the endogenous myelin basic protein (MBP) 
gene.  Fusion genes prepared with this promoter/en- 
hancer and a  Lac Z  reporter gene are expressed only 
in oligodendrocytes and not in Schwann cells, whereas 
the endogenous MBP gene is expressed in both cell 
types. The level of transgene expression measured by 
nuclear run-on experiments is very substantial  and ri- 
vals that of the endogenous MBP gene.  Furthermore, 
this  1.9-kb DNA fragment directs transcription  on the 
same (or very similar)  developmental schedule as the 
endogenous gene.  These results indicate that the MBP 
promoter/enhancer  sequences are at least tripartite:  a 
core promoter,  the oligodendrocyte enhancer elements, 
and a third component that either expands the specificity 
of the oligodendrocyte enhancer to include Schwann 
cells or acts independently to specifically stimulate 
transcription  in Schwann cells. 
T 
HE myelin  ensheathments  of the major axons  in the 
central nervous system (CNS) ~  and peripheral nervous 
system (PNS) are remarkably similar in architecture 
and composition (26, 40) despite the fact that CNS myelin 
is elaborated by oligodendrocytes, a cell of neural tube origin 
(36),  while PNS myelin  is  synthesized  by Schwann  cells 
which are of neural crest origin (29). Although some myelin 
proteins are found only in one or the other myelin,  several 
proteins like myelin basic protein (MBP), proteolipid protein 
(PLP), and myelin-associated  glycoprotein (MAG) are com- 
mon to both types of cells (1, 31, 37, 54). These myelin pro- 
teins are expressed only in the two types of myelinating cells 
and in no other cell of the body. A common expectation  is 
that each of the genes encoding these proteins is controlled 
by a set of cis-acting elements and trans-acting proteins that 
stimulate  transcription  in both cell types. 
Early studies (24, 25, 43) focused attention on sequences 
extending  1.3-kb upstream of the MBP transcription  start 
site as being important  in MBP gene regulation.  The results 
of Roach et al. (43, 55) showing that the transcription  of the 
truncated MBP gene of the shiverer mutant mouse proceeds 
with the same efficiency and cell-type specificity  as that of 
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myelin-associated  glycoprotein;  MBE myelin basic protein; MHC-1, class 
1 major histocompatibility complex;  PLP,  proteolipid;  PNS,  peripheral 
nervous system;  VSV-G, vesicular stomatitis virus glycoprotein. 
the wild type gene indicates  that these cis-acting elements 
must reside 5' to the middle of intron 2, the 5' boundary of 
the shiverer  deletion.  The  gene  transfer  experiments  of 
Kimura et al. (25) further define the location of the tissue- 
specific transcription  elements by showing that the MBP in- 
tronic  sequences were not necessary for brain-specific  ex- 
pression.  Taken together,  these two studies  show  that  the 
most likely locations of the binding sites for tissue- and cell- 
specific trans-acting factors are exon 1 of the MBP gene and 
the 1.3-kb sequence lying upstream of the cap site. 
Subsequent studies of the sites within this 1.3-kb sequence 
that are able to bind trans-acting proteins  have revealed  a 
complex of elements in the 5' promoter region of the MBP 
gene that are important  in general  transcription  (3,  11, 34, 
48, 49, 50). 
A critical  evaluation of the specificity, efficiency, and the 
completeness of the genetic elements  lying within  the  1.3- 
kb fragment  has  not been undertaken as yet and it is not 
known whether these elements  promote expression only in 
oligodendrocytes and Schwann cells and how efficiently. In- 
deed, several  recent  experiments  have raised concern that 
this DNA fragment may not contain the full complement of 
genetic elements necessary for efficient, cell specific expres- 
sion. Friedrich et al. (15) created transgenic mice which bore 
a fusion gene fashioned from the MBP promoter, the vesicu- 
lar stomatitis  virus glycoprotein (VSV G) gene coding re- 
gion  and  SV4o splice  and  polyadenylation  signals.  The 
animals  expressed the VSV G protein in oligodendrocytes 
but only weakly.  Furthermore,  the mice exhibited source 
neuronal dystrophy suggesting that neurons were affected by 
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this apparent breakdown in specificity of expression was an 
inherent property of the MBP promoter/enhancer sequences 
used, or whether the SV40 sequences modified the specific- 
ity, a phenomenon previously observed by others (7, 45). In 
separate studies Yoshioka et al. (56) and Turnley et al. (53) 
used 1.3 kb of 5' MBP sequence to promote expression of 
an appended class 1 major histocompatibility complex anti- 
gen (MHC-1). While both studies reported expression of the 
transgene in oligodendrocytes, they also reported significant 
expression in testes,  seminiferous tubules,  intestinal villi, 
liver, and lung. 
In the present communication, we show that a 1.9-kb frag- 
ment of the MBP promoter/enhancer sequence lying just 5' 
of position  +36 contains the necessary cis-acting genetic 
elements for the abundant and cell-specific expression of se- 
quences appended to it. The level of gene expression for the 
transgene, measured by nuclear run-on assays, rivals that of 
endogenous myelin basic protein gene. Furthermore, expres- 
sion of the protein encoded by the transgene follows the same 
developmental schedule as the endogenous MBP. However, 
unlike the endogenous gene, the transgene is expressed only 
in oligodendrocytes and not in Schwann cells. These results 
indicate that the MBP promoter/enhancer sequences are at 
least tripartite: the core promoter, the oligodendrocyte en- 
hancer element(s),  and a  third component that either ex- 
pands  the  specificity of the  oligodendrocyte enhancer to 
include Schwann cells or acts independently of the oligoden- 
drocyte enhancer and specifically stimulates transcription in 
Schwann cells. 
Materials and Methods 
Creation and Idena'fication of Transgenic Mice 
DNA used to generate transgenic mice was prepared from the plasmids il- 
lustrated in Fig.  1 by digestion with Not-1  and separation of the resultant 
fragments by gel electrophoresis. DNA was purified from agarose gels by 
2  rounds of adsorption to and elution from Geneclean (Bio 101, La Jolla, 
CA). The DNA was dissolved in microinjection buffer (10 mM Tris-HC1, 
pH 7.4, 0.2 mM EDTA), filtered twice through 0.2/~m filters and its concen- 
tration adjusted to 5  ng//~l (estimated by ethidium bromide staining). 
Transgenlc mice were produced in the Mount Sinai School of Medicine 
Transgenic  Core  Facility  (New  York).  Microinjection and  manipulation 
procedures  were  as  described  by  Hogan  et  al.  (21)  with  only  minor 
modifications.  C57B1/6J  x  DBA/2J  FI  hybrid  mice  were  used  as  the 
source of fertilized eggs which were re-implanted into CD-1 pseudopreg- 
nant females.  Transgenic  founders  were  identified by  polymerase  chain 
reaction (PCR) using synthetic oligonucleotide primers specific for the Lac 
Z  transgene. 
Histochemistry and Immunofluorescence 
Mice were anesthetized and fixed by vascular perfusion with buffered 4 % 
formaldehyde.  For  cryotomy,  tissue  pieces  were  infiltrated  with  20% 
buffered sucrose, frozen, and stored at -80~  Sections, 4-30 t~m thick, 
were thaw mounted on gelatin-coated slides and stored at -20~  Tissue 
fixed but not frozen was sectioned serially at 50-ttm thickness with a Vibra- 
tome (Lancer, St. Louis, MO). 
For/~-galactosidase histochemical stain, cryostat or vibratome sections 
were incubated at 20 ~ or 37~  for 30 rain to 5 d  in a solution containing 
35  mM  K3Fe(CN)6,  35  mM  K4Fe(CN)6,  2  mM  MgCI2,  0.01%  sodium 
deoxycbolate,  0.02%  NP-40,  0.15  M  NaCI,  10  mM  Na2HPO4,  and 
0.03-0.1% X-gal (5-bromo-4-chioro-3-indolyl-/3-D-galactoside) final pH 7.0. 
For immunofluorescence, cryostat sections were stained with the follow- 
ing primary antibodies, used singly or in combination: anti-~-galactosidase 
(rabbit;  Cappel  Laboratories,  Malvern,  PA)  (mouse;  Promega  Biotec, 
Madison, WI), anti-myelin basic protein (rabbit, anti-peptide amino acids 
1-20; mouse, monoclonal) (16), anti-2',3'-cyclic nucleotide phosphohydro- 
lase (rabbit,  gift of D.  Colman,  Columbia University, New York),  anti- 
myelin-associated glycoprotein (rabbit, gift of R. Quarles), anti-P0 (rabbit, 
gift of D. Colman), anti-glial fibrillary acidic protein (GFAP) (rat, gift of 
V. Lee, Pennsylvania School of Medicine, Philadelphia, PA), anti-neurofila- 
ment (mouse,  monoclonal, gift of V.  Lee;  rabbit, Chemicon, Temecula, 
CA). These were visualized with fluorescein- or biotin-conjngated, species- 
specific secondary antibodies (Amersham Corp.,  Arlington Heights,  IL) 
and rhodamine-conjugated streptavidin (Molecular Probes Inc., Junction 
City,  OR).  Preparations were counterstained where appropriate with the 
nuclear dye DAPI (4',6'-diamidino-2'-phenylindole) or with m-phenylene- 
diamine (39). After staining, coverslips were mounted with buffered glyc- 
erol; for preparations using fluorescein, the glycerol contained 2% 1,4-di- 
azabicyclo-(2,2,2)-octane to reduce fading (23). 
Determination of Transgene Copy Number 
The  3.1-kb  coding  region  of  Lac  Z  labeled  with  ct-[a2p]-dCTP  (3,000 
Ci/mmol) by random-priming (Klenow large fragment, Promega Biotec) 
was hybridized to duplicate,  5-ttg samples of transgenlc mouse genomic 
DNA adsorbed onto nitrocellulose membranes (slot blots) for 24 h at 42~ 
in 6x SSC (lx SSC =  0.15 M NaC1 in 15 mM sodium citrate), containing 
50%  formamide,  5x  Denhardt's solution, 0.6%  SDS,  50 mM phosphate 
(pH 6.9), and 0.2 g/l sonicated salmon sperm DNA. The blots were washed 
with solutions of increasing stringency up to 0.1x  SSC containing 0.5% 
SDS at 550C, and then exposed to X-ray film. Known amounts of the Lac 
Z coding region were included on the membranes to determine the number 
of copies of the transgene by visual comparison of the autoradiogram film 
darkenings. 
~-Galactosidase Assays 
Organs were rapidly dissected from mice and frozen separately on dry ice. 
Partially thawed samples were homogenized (Tekmar tissuemizer, Tekmar 
Co.,  Cincinnati,  OH)  at 0~  in  1-2 ml of 50 mM  Tris buffer,  pH  7.3, 
containing 250 mM sucrose,  150 mM NaC1,  5 mM EDTA,  1 mM DTT, 
and 0.1 mM leupeptin. Aliquots of each homogenate were stored at -80~ 
The protein content of the homogenates was determined in duplicate assays 
(30). Enzyme activity was measured in duplicate assays using o-nitrophenol 
galactopyranoside (Sigma Chemical Co., St. Louis, MO) as the substrate, 
in an adaption of the/~-galactosidase assay protocol recommended by the 
vendor (Sigma Chemical Co.). Two or three aliquots from each assay were 
removed (typically at 5-30-rain intervals) and added to tubes containing 
Na2CO3  (0.5 M  final) to terminate the reaction; each time-point was ren- 
dered optically clear using SDS (0.5%  final) and centrifugation. Enzyme 
specific activity was determined from the average absorbance change at 420 
nm per minute over the entire time course, using an extinction co-efficient 
for o-nitrophenol of 4,800 M-t.cm -1 (12). Comparison of the enzyme ac- 
tivity in homogenates with that of purified fl-galactosidase diluted in brain 
homogenate enabled determination of the absolute amounts of enzyme in 
organs from transgenic mice. 
Western Blots 
Aliquots of brain and spinal cord homogenates were diluted to a protein 
concentration of 2 mg/ml in 125 mM Tris, pH 6.8, containing 5% sucrose, 
5 % SDS, 0.5 % (vol/vol)/3-mercaptoethannl, and a trace of bromophenol 
blue then heated to 50~  for 10 min. This sample preparation procedure 
is a slight modification of that of Laemmli (28), which avoids aggregation 
of the myelin proteolipid and Wolfgram proteins. Purified/3-galactosidase, 
diluted to 1 ttg/mi in 5 mg/ml BSA (BSA, fraction V; Boehringer-Mannheim 
Biochemicals, Indianapolis, IN),  was used as a standard; aliquots of this 
solution were added to wild-type brain homogenates for electrophoresis to 
ensure the/3-galactosidase behaved, in subsequent steps, similarly to that 
present in transgenlc tissue.  The samples were electrophoresed in 6.5% 
SDS-polyacrylamide gels (28) then electroblotted onto Immobilon-P (Mil- 
lipore, Bedford, MA) for 2 h at 0~  using a 0.25 M  Tris-l.92 M glycine 
transfer buffer (51).  The membrane was blocked overnight at 4~  in TBS 
(25 mM Tris buffer, pH 7.4,  136 mM NaCI, and 36 mM KC1) containing 
0.5%  (vol/vol) NP-40,  3%  BSA,  and  10%  (vol/vol) normal goat serum 
(Sigma). Unless otherwise specified, subsequent processing of the western 
blots was carried out at 20~  in wash buffer (TBS, 0.5%  [vol/vol] NP-40, 
1% BSA and 1% [vol/vol] normal goat serum). Fractionated rabbit anti-/3- 
galactosidase antiserum (Rockland, Gilbertsville, PA) and afffinity-purified 
goat anti-rabbit IgG antibodies conjugated to alkaline phosphatase (Pro- 
mega Biotec) were freshly diluted (1:10,000  and  1:7,500,  respectively) in 
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and  spinal core homogenates (each  15  t~g/ml)  for 30  min then passed 
through 0.45/~m Millex-HV filters (Millipore Continental Water Systems, 
Bedford, MA). The blots were incubated in primary antiserum for 60 min, 
incubated for 45 min in several changes of wash buffer then incubated for 
30 min in secondary antibody. After a further 45-min wash period using 
0.5 % NP-40 in TBS, alkaline phosphatase-antibody complexes on the blots 
were visualized using the Protoblot detection system (Promega Biotec). 
Nuclear Run-on Assays 
Nuclei were prepared using the method of Wiktorowicz and Roach (55). 
Briefly,  brains were rapidly removed from decapitated transgenic mice, 
rinsed in ice-cold PBS and homogenized in 20 mM Tris buffer, pH 6.9, con- 
raining 0.75 M sucrose, 0.I % (vol/vol) Triton X-100 (Boahringer-Mannhe'ma 
Biochemicals),  5  mM  fl-mereaptoethanol and  1  mM  MgC12 using  a 
Dounce homogenizer (Wheaton, Millville, NJ).  10 strokes of the loose- 
fitting pestle and 20 strokes of the tight-fitting pestle were used to dissociate 
the tissue which was then mixed with sucrose cushion buffer (20 mM Tris 
buffer,  pH  6.9,  2.1  M  sucrose,  5  mM  fl-mercaptoethanol and  1  mM 
MgC12) and layered over 10 ml of sucrose cushion buffer in a polypropyl- 
ene ultracentrifuge tube (SW28;  Beckman Instruments, Palo Alto, CA). 
Nuclei were pelleted at 15,000 rpm for 60 rain at 4~  gently resuspended 
in 3 ml of wash buffer (20 mM Tris buffer, pH 6.9, 20% [vol/vol] glycerol, 
140 mM KCI, 10 mM MgC12, 1 mM MnCI~,  and 5 mM fl-mercaptoetha- 
nol), and then centrifuged for 5 min at 3,000 rpm in a Beckman JS-5.2 rotor. 
Transcription reactions were performed according to  the  method of 
Chen-Kiang and Lavery (8) with several modifications. Fresh nuclei pellets 
were resuspended in 1 ml of transcription buffer (wash buffer, pH 7.9, con- 
taining 14 mM fl-mereaptoethanol, 1 mM of each of ATE CTP, GTP, and 
S-adenosylmethionine, and 20 mg/ml tRNA), centrifuged for 3 min at 3,000 
rpm and then resuspended in 190/zl of transcription buffer.  After adding 
0.5 mCi of ct-[32Pl-UTP  (800 Ci/mmol; Du Pont, Wilmington, DE) dis- 
solved in 10 #1 of transcription buffer, the nuclei were incubated at 0~  for 
10 min. The transcription assay was carried out for 15 rain at 30~  The 
reaction mixture was centrifuged for 10 s to separate the nuclei and the su- 
pernatant fluid removed. The nuclei were then lysed by the addition of 300 
~1 of 10 mM Tris buffer, pH 7.4, containing 0.5 M NaCI, 50 mM MgCI2, 
2 mM CaCI2,  300 U of RNase-free DNase I (Boehringer-Mannheim Bio- 
chemicals) and 40 U of RNAsin (Promega Biotec). Proteinase K (Sigma 
Chemical Co.), sodium sarcosinate (SLS), and EDTA (final 0.3 mg/ml, 
0.5% and 5 mM, respectively) were added to the lysate and the mixture in- 
cubated for 30 rain at 37~  An equal volume of I0 mM Tris buffer, pH 
7.0, containing 6 M guanidinium isothiocyanate, 1% SDS, and 0.3 M fl-mer- 
captoethanol was added, the solution was then layered over a 1.2-ml cushion 
of 5.7 M CsC1 and centrifuged overnight at 45,000 rpm using a Beckman 
TLS-55 rotor (9). The RNA pellet was dissolved in 10 mM Tris buffer, pH 
7.4,  containing 1 mM EDTA, and precipitated in ethanol. 
Hybridizations 
Deoxyribonucleic acid probes used for detecting 32P-labeled nascent tran- 
scripts from nuclear run-on assays were as follows: MBP, 4 kb of mouse 
genomic clone (10) encompassing exon 2 and the 5' end of intron 2 (Kpnl 
to BamH1  fragment); Lac Z, the entire 3.1-kb coding region (20);  non- 
specific binding, pBluescript II SK+. The appropriate portions of the MBP 
and Lac Z gene were sub-cloned into pBluescript II SK+ (Stratagene, La 
Jolla,  CA).  Bacteria  (XL-1  blue;  Stratagene)  transformed  with  these 
phagemids were grown in the presence of VCSMI3 helper phage (Strata- 
gene) and antisense single-stranded DNA was purified from the culture su- 
pernates  by  polyethylene  glycol-ammonium  acetate  precipitation  and 
phenol-chloroform extractions as  recommended by  the  vendor.  Alkali- 
denatured (2 M NaOH-3 M  NaCI incubated at 25~  for 25 rain) single- 
stranded probes were slot-blotted onto nitrocellulose filters (0.2/zg DNA/ 
slot).  In  some experiments linearized,  heat denatured double-stranded 
DNA was used instead of single-stranded antisense DNA. Blots were pre- 
hybridized for 2 h in 6x SSC, 5x Denhardt's solution, 0.6% SDS, 50 mM 
phosphate, and 0.2 g/L sonicated salmon sperm DNA at 65~  Hybridiza- 
tion solutions containing the run-on transcripts were hybridized succes- 
sively to three slot-blots of  the target DNA sequences; each cycle of hybrid- 
ization was 48 h. Blots were washed and then incubated for 20 min at 20~ 
in 2x  SSC containing 0.2%  SDS and 10 #g/ml of RNase A  followed by 
an incubation of 20 min at 20~  in 2x SSC containing 0.2% SDS and 100 
t~g/ml of proteinase K. Finally, the blots were washed for 10 min at 20~ 
in 2x  SSC containing 0.2% SDS and exposed to X-ray film. 
Ribonuclease Protection Assays 
Samples of total RNA purified from brain, spinal cord, or peripheral nerve 
(9) were hybridized for at least 12 h at 45~  in 0.2 M Pipes buffer, pH 6.4, 
containing 80% formamide, 2 M NaC1, and 5 mM EDTA with labeled an- 
tisense RNA transcripts specific for either the transgene or the endogenous 
MBP gene (33). Single-stranded RNA was digested at 30~  for 60 rain with 
ribonucleases A and T1 (final concentrations: 40 ,~g/mt and 10,000 U/ml, 
respectively). After proteinase K digestion (30~  for 60 min) samples were 
electrophoresed  on nondenaturing, 6% acrylamide gels, dried, and exposed 
to X-ray film. 
Quantification of  Autoradiograms and Western Blots 
Autoradiograms from nuclear run-on and ribonuclease protection assays 
were digitized using a Datacopy GS plus fiat-bed scanner (Xerox) and ana- 
lyzed on an Apple Macintosh computer using the software program, NIH 
Image, version 1.43 (written by Wayne Rasband). Several exposures of each 
autoradiogram were used to ensure signal intensities lay within the linear 
response ranges of  the film. Photographs of western blots were treated simi- 
larly. 
Results 
The MBP Gene Promoter~Enhancer Elements and the 
Fusion Genes, Mf3P, and MI3G 
Earlier work by us (15) and others (3, 11, 34, 48, 49, 50) indi- 
cate that important cis-acting genetic elements lie upstream 
of the first exon of the murine MBP gene. This region of 
DNA was shown to be capable of promoting transcription 
both in vitro and in vivo in transgenic mice. Although the 
results obtained with transgenic mice showed that the fusion 
gene was capable of expression in oligodendrocytes, the cel- 
lular specificity was incompletely documented and little in- 
formation is available about expression in other cells of the 
nervous system or elsewhere in the body. To study the cell 
specificity of expression promoted by the 5' upstream region 
of  the murine MBP gene (10), we constructed two expression 
vectors, each using different sequences for splice sites and 
polyadenylation  signals. The MBP portion of these vectors is 
a DNA fragment that extends from position +36 to position 
-1907  of the MBP gene.  This sequence was ligated to a 
polylinker containing HindlII, EcoR1, and BamH1 sites. The 
splice and polyadenylation signals were supplied by either a 
portion of the PLP gene (exon 6, intron 6, and exon 7) or the 
human/3-globin genes (exon 2, intron 2, and exon 3). These 
splice and polyadenylation  signals were cloned into a plasmid 
containing the MBP promoter/enhancer sequences leaving a 
unique BamH1 site into which cDNAs could be inserted. For 
convenience,  synthetic  oligonucleotides  containing  Not-1 
sites were inserted at both sides of the entire assembly (Fig. 
1).  For the purpose of this study, we chose the truncated 
Escherichia coli Lac Z gene (20) as a reporter gene because 
/3-galactosidase  is functionally neutral in many eukaryocytes 
(14) and the assay for its activity is very sensitive. 
The fusion genes were excised from the plasmid, purified 
and used to prepare transgenic mice. Five founder mice were 
created with Mt3P and two with M/3G. Sections of  brain, spi- 
nal cord, and peripheral nerve from all lines were examined 
histochemically with the chromogenic substrate, X-Gal. Of 
the M/3P lines, four exhibited a pattern of/3-galactosidase 
staining that was consistent with oligodendrocyte-specific 
expression.  One  of these  showed,  in  addition,  a  small 
amount of punctate staining of the CNS. The fifth MI3P line 
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Figure  L Diagram of  MBP and  MBG  transgenes.  A restriction  frag- 
ment extending from a Sac-1  site  (-1907) to a BspM1 site  (+36) 
of the MBP  promoter/enhancer was ligated  to a polycloning site 
(underlined  sequence) and subcloned into  a derivative  of pUCI9 
containing  splice  and polyadenylation  signals  supplied  by either  a 
Pst-1  fragment of  PLP gene  containing  part  of  exon  6, intron  6, and 
exon 7, or a BamHI-Pst-I fragment of  murine B-globin gene.  The 
Lac Z gene used as a reporter  is a truncated  version  described by 
(20). Not-I sites  were inserted  at either  end of  the constructs  for 
easy excision  of  the  transgene.  The sequence shows the  position  of 
transcription  initiation  with a horizontal  arrow; the superscript  36 
indicates  position  +36 of  the MBP  gene and the end of  the MBP 
promoter/enhancer sequence used here. 
did not express detectable amounts of the Lac Z gene. Of the 
two MEG lines, one expressed the transgene in an oligoden- 
drocyte-specific manner that was indistinguishable from the 
M/3P mice. The second did not express the transgene at lev- 
els detectable by histochemistry. 
Cell and Tissue Specificity of  /3-Galactosidase 
Accumulated in MBP3 Transgenic Mice 
Preliminary experiments in which organs and tissues of het- 
erozygous M/3P transgenic mice were incubated in solutions 
of X-Gal revealed a striking specificity of transgene expres- 
sion. Only neural tissue and, specifically, the CNS compo- 
nent, exhibited appreciable j3-galactosidase  activity. Nota- 
bly, the PNS was devoid of detectable transgene expression. 
This specificity is illustrated in Fig. 3 A which shows intense 
staining of the section of spinal cord but no detectable stain- 
ing in the attached peripheral nerve roots. The specificity in 
expression  of j3-galactosidase  was  further  explored  and 
quantified by spectrophotometric assays of/3-galactosidase 
activity of cell free extracts prepared from various tissues of 
transgenic and non-transgenic litter-mate mice (Table I). As 
shown in Table I, only the CNS tissue of the M/3P 3 and M/3P 
5 mice contained/3-galactosidase activity that was demon- 
strably  higher  than  the  comparable  tissue  of  the  non- 
transgenic litter mates.  Consistent with the results of the 
gross staining of pieces of spinal cord and dorsal root gan- 
glia, only the CNS tissue expressed the transgenic/~-galac- 
tosidase gene. Results qualitatively identical to these were 
obtained with MBG mice, showing that the PLP gene se- 
quences used for splice/polyadenylation signals of the M~P 
mice did not appreciably contribute to the specificity of ex- 
pression. Thus this specificity is conferred by the MBP pro- 
moter/enhancer sequences alone. 
Table L ~-Galactosidase Levels in Transgenic and 
Wild-  Type Tissues 
M~P3  MBP5  Wt 
Ozg/gm wet weight tissue) 
Brain  2.78  3.66  0.03 
Spinal cord  0.29  0.51  0.00 
Sciatic nerve  0.00  0.01  0.00 
Thymus  0.00  0.01  0.01 
Lung  0.00  0.02  0.01 
Heart  0.00  0.01  0.01 
Liver  0.11  0.06  0.06 
Spleen  0.02  0.05  0.01 
Adrenals  0.00  -  0.00 
Kidneys  0.08  O. 13  O. 11 
Gonads  -  0.01  - 
Skeletal muscle  0.00  0.00  0.01 
Adipose  0.01  0.03  - 
To map the regional distribution and cellular localization 
of/3-galactosidase activity, we prepared sets of serial sec- 
tions through complete sagittal half brains  stained alter- 
nately for myelin and for/3-galactosidase. The/~-galactosi- 
dase histochemical reaction yielded very strong staining of 
M~P3  specimens,  with  reactivity  concentrated  in  white 
matter throughout the brain and the major white matter tracts 
such as the callosal radiations, anterior commissure, fornix, 
and internal capsule clearly delineated (Fig. 2 A). This pattern 
was nearly identical to that obtained with immunoperoxi- 
dase staining for myelin basic protein (Fig. 2 B). Sections 
from control nontransgenic mice, stained for ~-galactosi- 
dase, showed no reaction product and were nearly invisible 
(Fig.  2 C). 
Strong ~-galactosidase staining was also found in white 
matter throughout the transgenic spinal cord. By contrast, 
PNS, including spinal  roots and trigeminal nerve and gan- 
glion, was consistently negative for B-galactosidase activity 
in M/3P3 mice (Fig. 3 A). High magnification revealed two 
components  of fl-galactosidase  staining  in  M/3P3  mice. 
First, both major white matter tracts and small bundles of 
myelinated axons were filled with and clearly delineated by 
diffuse staining of moderate intensity (Fig. 3 B). Where my- 
elinated axons are sparse, as in the cerebellar granular layer 
or in parts of the cerebral cortex, individual stained axons 
could be distinguished (Fig. 3 D). Second, small cell bodies 
were strongly stained. These cells, 8-12 #m in diameter and 
filled to opacity with reaction product, were found through- 
out the CNS, at high density in white matter and at lower 
density in gray matter. In favorable sections one could follow 
stained processes connecting those stained cell bodies with 
bundles of myelinated axons (Fig. 3 B), a pattern character- 
istic of Golgi-impregnated oligodendrocytes (42). 
Immunofluorescence with antibodies against the/3-galac- 
tosidase yielded images nearly identical in pattern to those 
obtained  with  the  histochemical  reaction.  White  matter 
tracts  exhibited  uniform,  weak  immunofluorescence and 
contained intensely labeled small cell bodies whose peri- 
karya appeared filled with antigen (Fig. 3 C). Simultaneous 
staining with the nuclear dye DAPI revealed many ceils in 
white matter, and a majority in gray matter, which were not 
immunostained. Gray matter in different regions contained 
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activity is concentrated in white mat- 
ter of M~P3  transgenic  mice.  (A) 
Sagittal vibratome section from  brain 
of transgenic MBP3 mouse, stained 
with X-gal for bacterial/5-galactosi- 
dase  activity. Major  white  matter 
structures  are clearly delineated by 
the histochemical reaction. The tri- 
geminal nerve and ganglion (arrow- 
head in A) are not stained. (B) Nearby 
section  from  the  same  specimen 
stained  by  immunoperoxidase  for 
myelin basic protein, for comparison 
with A. (a) anterior commissure; (c) 
callosal radiations; (f) fornix; (i) in- 
ternai capsule. (C) Vibratome sec- 
tion  from  control  (nontransgenic) 
mouse brain  incubated with X-gal, 
showing lack of staining throughout 
the brain.  Bar, 1 mm. 
immunofluorescent cell  bodies in  proportion to  the local 
density of myelinated axons. 
To positively identify the cells expressing the transgenic 
protein,  we  prepared cryostat sections of spinal  cord and 
brain  for  simultaneous  two  color  immunofluorescence, 
recording B-galactosidase in one channel and one of several 
cell-specific marker proteins in  the  second channel.  The 
/3-galactosidase  immunoreactive cells and  their processes 
showed no immunoreactivity for neurofilament protein (a 
neuron-specific marker) or for glial fibrillary acidic protein 
(GFAP; an astrocyte marker).  CNP (2',3'-cyclic  nucleotide 
phosphohydrolase) is a myelin-specific protein; in CNS, it is 
found only in oligodendrocytes, where it is concentrated at 
the plasmalemma (6,  18, 52). In cryostat sections CNP im- 
munostaining yielded bright rings of  fluorescence  at the plas- 
malemmas  of oligodendrocytes,  a  pattern  we  previously 
Gow et al. Separate Enhancers for CNS and PNS  609 Figure 3. Localization of transgenic protein in MBP3 mice. (A) Spinal cord with attached spinal roots and nerves, incubated in X-gal. 
Spinal cord is stained but the peripheral nerves are not. (B) Vibratome section from caudoputamen, incubated with X-gal. Broad stained 
bands (asterisks)  are bundles of myelinated axons. Oligodendrocyte cell bodies are st fined, as are fine processes (arrowheads),  connecting 
the oligodendrocyte cell bodies with myelin sheaths. (C) Cerebellar cortex, immunostained with polyclonal rabbit anti-B-galactosidase. 
Oligodendrocyte cell bodies, found in granular layer (GL) and subcortical white matter (WM), are strongly immunoreactive. In addition, 
the subcortical white matter shows diffuse fluorescence. The molecular layer (ML), which is virtually devoid of myelin in mouse, shows 
no immunofluorescence. (D) Granular layer of cerebellar cortex, stained with X-gal. A single stained myelinated axon (arrowhead) can 
be followed as it courses through the granular layer. Abbreviations as in C. Bars: (B and C) 40 #m; (D) 20 #m. 
reported  in  semithin  frozen  sections  (18).  By  contrast, 
B-galactosidase irranunofluorescence  filled the perikaryal cy- 
toplasm of the same cells (Fig. 4). More than 95 % of cell 
bodies positive for/3-galactosidase, were also clearly posi- 
tive for CNP and were therefore identified as oligodendro- 
cytes; the remainder presented equivocal images. In similar 
preparations, immunofluorescence for neurofilament or GFAP 
antibodies never showed coincidence with that for #-galac- 
tosidase, indicating that the enzyme is not present in neurons 
or astrocytes of M/~P3 mice. 
These data  show clearly that the M/~P transgene is ex- 
pressed strongly in  oligodendrocytes of M~P3  mice.  The 
perikarya and processes of  these cells are diffusely filled with 
~-galactosidase, detected both histochemically and by im- 
munofluorescence with  two  different antibodies.  By con- 
trast, expression in neurons and astrocytes occurs at levels 
below detection with our techniques. 
Temporal Control of Transgene Expression During 
CNS Development 
Myelin is almost completely absent from newborn mouse 
brain;  its  formation begins  shortly  after birth  in  a  tract- 
specific sequence and reaches a peak of intensity at the end 
of the third postnatal week. To determine the temporal pat- 
tern of  transgene expression, we stained sections of forebrain 
from 7-, 14-, and 21-d old M/3P3 transgenic mice for/3-ga- 
lactosidase (Fig. 5). At 7 days postnatal (dpn) (Fig. 5 A), lit- 
tle reaction product was produced. Sections were nearly in- 
visible at  low magnification,  although high magnification 
showed some stained cell bodies concentrated in areas des- 
tined to become white matter. A marked increase in overall 
staining was seen at 14 dpn, and major white matter tracts 
were clearly delineated (Fig. 5 B). These showed a further 
increase in staining intensity at 21 dpn (Fig. 5 C); staining 
at this age was however still weaker than in adult specimens. 
This pattern is consistent with the known accumulation of 
myelin in developing mouse brain (22, 47). 
Typically, myelination is preceded by intense gliogene- 
sis  (44),  and  early  formed oligodendrocytes differentiate 
and become immunoreactive for MBP even before myelin 
sheaths appear (46). In spinal cord and medulla of newborn 
MflP3  mice we  found little myelin, but many cells  were 
marked by X-gal staining for/3-galactosidase. Differentiating 
oligodendrocytes exhibit a regular temporal progression in 
gene activation; among myelin specific proteins CNP is ex- 
pressed early and MBP later. In two-color immunofluores- 
cence preparations, we found CNP in all cells which were 
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dendrocyte-specific protein 2',3'-cyclic nucleotide phosphohydro- 
lase (CNP). A cryostat section from spinal cord of an MBP3 trans- 
genic mouse was stained by two-color double irnmunofluorescence 
for CNP (antiserum raised in rabbit) and for B-galactosidase (mAb) 
and counterstained with the nuclear dye DAPI. The identical field 
is shown in the three panels, viewed with fluorescein (ti),  rhoda- 
mine (B), and DAPI (C) fluorescence. 13 doubly immunofluores- 
cent perikarya are illustrated; two are marked with arrowheads. 
Bar, 20 t~m. 
Figure 5. Expression of MBP transgene during postnatal develop- 
ment. Coronal vibratome sections were cut at the level of the ante- 
rior commissure of brains from MBP3 transgenic mice 7 (A), 14 
(B), and 21 (C) days after birth and incubated with X-gal. Staining 
was negligible at 7 d and increased progressively thereafter. Bar, 
lmm. 
immunofluorescent for B-galactosidase, indicating that early 
expression of the transgene is limited to oligodendrocytes. 
However, many CNP-positive perikarya lacked detectable 
B-galactosidase, suggesting that the MflP transgene, like the 
endogenous MBP gene, is activated after the CNP gene. 
Comparison of MBP and B-galactosidase immunofluores- 
cence yielded a different pattern: almost all cells positive for 
either antigen were also positive for the other (Fig. 6). Thus, 
the endogenous MBP gene and the M/SP transgene may be 
activated simultaneously within each maturing cell. 
Variation of  Expression 
The localization of/~-galactosidase was examined by his- 
tochemistD" in all five MBP lines produced and both MBG 
lines.  All five of the lines which expressed detectable en- 
zyme showed striking  localization of reaction product to 
CNS white matter (Fig, 7), and all showed strongly stained 
oligodendrocyte  cell  bodies  and  processes  and  weakly 
stained myelin internodes when examined at high magnifica- 
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tosidase (:3GAL)  immnnoreactivity in immature oligodendrocytes. 
A cryostat section from the spinal cord of a postnatal day 1, M/~P3 
transgenic mouse was stained by two-color double immunofluores- 
cence and counterstained with the nuclear dye DAPI. The identical 
field is shown in the three panels, viewed with rhodamine (A), fluo- 
rescein (B), and DAPI (C) fluorescence.  Immunoreactive  cell bod- 
ies are indicated by arrowheads. Bar, 20 #m. 
tion. However, the different lines showed some variation on 
this theme. Variation in the expression of transgenes in dif- 
ferent lines of mice carrying the same transgene are fre- 
quently observed (5) and thought to arise because the trans- 
genes of each line are integrated into a different site on the 
host chromosome and thus differently influenced by the sur- 
rounding endogenous sequences.  Alternatively, the trans- 
gene of some lines may have undergone rearrangement and 
modification before insertion into the host chromosome. 
In addition to diffuse, strong staining of oligodendrocytes, 
M/3P5 also showed fine granular staining in some areas of 
CNS, including cerebral cortex and hippocampus. A second 
variation is exhibited by the M/~P30 line: while expression 
is limited to oligodendrocytes, the histochemical reaction 
colored white matter unevenly (Fig. 7), suggesting that ex- 
pression is strong in some oligodendrocytes and weak or ab- 
sent in others. The M/~G46 line showed strong expression of 
the transgene in oligodendrocytes, with a very small amount 
of granular staining of the type seen in M/3P5. 
Of the five #-galactosidase expressing  lines examined, 
four showed absolute suppression of transgene expression in 
peripheral nerve. The fifth, M/3P30, followed  this pattern but 
did exhibit very weak and irregular staining of trigeminal 
nerve, in regions close to the CNS-PNS boundary. 
The M[3P Transgene Is Efficiently Transcribed 
The steady state level of MBP mRNA in brain suggests that 
the MBP promoter may be one of the strongest in the CNS. 
It is not known whether this strength is an intrinsic property 
of  the core promoter or whether distal elements, like domain 
control regions, or chromosomal position also play impor- 
tant roles.  The observation that the transgenic M/~P pro- 
moter contain the genetic elements conferring strict oligo- 
dendrocyte specificity and the appropriate temporal control 
of expression prompted us to compare the relative strengths 
of the transgene and endogenous gene promoters by a vari- 
ety of techniques. 
The levels of/~-galactosidase activity found in transgenic 
brain and spinal cord (3 and 0.5 #g/gm wet weight tissue; Ta- 
ble I) are very small when compared to the abundance of 
MBP in these tissues (,~1  mg/gm wet weight).  This dis- 
crepancy suggested that much of the transgene product may 
turn over rapidly or be otherwise enzymatically inactive. 
However, Western blot analyses of transgenic tissue did not 
support this possibility as shown in Fig. 8. Only a single pro- 
tein band of 116 kD was revealed by inununo probing of the 
Western blot.  Comparison of the intensity of staining of 
these bands to those obtained with the graded amounts of 
highly  purified  /3-galactosidase  verified  the  levels  deter- 
mined by direct enzyme assay shown in Table I. Comparison 
of these numbers to the level of MBP in brain  (1  mg of 
MBP/gm wet weight) indicates that/~-galactosidase accumu- 
lation is r  that of MBP in transgenic brain.  However, 
when transgene expression was estimated by Northern blot 
rather than Western blot a much higher level relative to that 
of MBP was indicated. Visual comparison of Northern blot 
autoradiograms suggested that the steady-state ratio of  ~-ga- 
lactosidase  to  MBP  mRNA  was  about  10  -2  (data  not 
shown). This ratio was corroborated by RNase protection as- 
says shown in Fig. 9. In that figure the MBP signal obtained 
with 0.3 #g of total brain RNA is comparable to the/3-galac- 
tosidase signal obtained with 30 #g of brain RNA after al- 
lowing  for  differences  in  probe  size,  composition,  and 
specific activity. Thus the ratio of transgene expression to 
endogenous MBP gene expression was either  10  -3 or  10  -2 
depending on whether accumulated protein or mRNA was 
used as the basis for estimating the level of  gene activity. This 
10-fold  difference might be  traced  to  the  differences  in 
The Journal of Cell Biology, Volume 119,  1992  612 Figure 7. Comparison of/3-galactosidase activity in brain of different M/3P and M/3G transgenic lines. Sagittal, 50-#m thick vibratome 
sections from brains of adult mice were reacted with X-gal. Bar, 1 mm. 
preferred codon usage between eukaryotes and prokaryotes. 
Alternatively the Lac Z gene used in the transgene is a trun- 
cated form (20) that initiates protein synthesis at the second 
ATG of the wild type mRNA  and that ATG is  not in the 
preferred context (27).  Thus the level of protein synthesis 
sustained by the/3-galactosidase mRNA may be dispropor- 
tionately low. 
The relative abundance of the mature mRNA or protein 
encoded by  it  are  poor  gauges  of the  relative  promoter 
efficiency since these levels can be modulated by posttran- 
scriptional and posttranslational events. Thus, although the 
ratio of/3-galactosidase to MBP is  exal0  -3,  and the ratio of 
their mRNA  is  •10 -2,  the ratio of the promoter strengths 
may be much larger. To better estimate the relative frequency 
of  transcription initiation of  the genes we have performed nu- 
clear  run-on  assays  which  directly  compare  the  relative 
amounts of nascent transcripts of the two genes in the same 
transcription reaction mixture.  The results of such experi- 
ments are shown in Fig. 10. Quantitative estimates of the rel- 
ative amounts of nascent transcripts were obtained by adjust- 
ing densimetric measurements  for the differences in base 
composition and the lengths of the unlabeled hybridization 
probes.  These results indicate that the levels of transgene 
transcription  in  M/3P3  and  M/3G  46  are  20-30%  and 
30-40%, respectively, of the endogenous MBP gene. These 
numbers are approximations since they do not take into ac- 
count differences in gene dosage. On the one hand, the trans- 
genic mice are heterozygous for the transgene but homozy- 
gous  for  the  MBP  gene.  On  the  other  hand,  there  are 
approximately 5-10 copies of the transgene present in the 
chromosome and we do not know how many of them are 
transcriptionally active. 
Figure 8. Western blot analysis of brain and spinal cord homoge- 
nates of M/3P3. Samples of M/3P3 brain and spinal cord homoge- 
nates and known amounts of purified /3-galactosidase (added to 
wild-type mouse brain homogenate) were electrophoresed in 6.5 % 
SDS-polyacrylamide gels. The separated protein bands were trans- 
ferred to PVDF membranes and probed with polyclonal rabbit anti- 
~3-galactosidase as described in Materials and Methods. Lane 1, 
120/~g protein from M/3P3 spinal cord; lane 2, 80 t~g protein from 
M/~P3 brain; lanes 3-6, 80 t~g protein from wild-type mouse brain; 
lanes 4-6, 10, 2, and 0.5 ng purified/3-galactosidase, respectively. 
MI~P3 Transgene Transcripts Are Not Detected 
in the PNS 
The  surprising  absence  of  /3-galactosidase  in  peripheral 
nerve of M/3P3 transgenic mice suggests that either the pro- 
tein is not synthesized in this tissue, is inactive, or is rapidly 
degraded.  We examined whether the peripheral nerve had 
detectable levels of/3-galactosidase mRNA and, therefore, 
was capable of synthesizing the enzyme. In preliminary ex- 
periments,  we could not detect/3-galactosidase mRNA  in 
Northern blot  analyses  of RNA  isolated  from peripheral 
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tion assays. The indicated amount of CNS RNA, PNS RNA or 
tRNA were hybridized to 32p-labeled antisense probes specific for 
MBP or Lac Z, treated with ribonuclease, and electrophoresed in 
a non-denaturing 6%  polyacrylamide gel.  An autoradiogram of 
relevant portions of the dried gel are shown. 
nerve under conditions that easily detected it in brain RNA 
(data not shown). We pursued these studies with RNase pro- 
tection analyses since these have a much greater sensitivity. 
These analyses (Fig. 9) showed that we were unable to detect 
Figure 10. Estimation of in vi- 
tro  run-on  transcripts  from 
nuclei from brains  of MBP3 
and MBG46 transgenic mice. 
Nuclear  run-on  experiments 
were performed as  indicated 
in  Materials  and  Methods. 
Autoradiograms of the mem- 
branes from the first of three 
successive hybridizations are 
shown. 
any/~-galactosidase mRNA in 70/~g of total RNA prepared 
from sciatic and trigeminal nerves under conditions that eas- 
ily detected MBP transcripts in 0.3/zg RNA. On the other 
hand, fl-galactosidase mRNA was easily detected in 30 #g 
CNS  RNA.  Two  conclusions  can  be  drawn  from  these 
RNase protection experiments. First, the steady state level 
of B-galactosidase mRNA in the CNS is '~1%  that of MBP 
mRNA, and second, the level of ~-galactosidase mRNA in 
PNS is not detectable by our methods. 
Discussion 
The transcription of eukaryotic genes is frequently thought 
of as being simultaneously controlled by two broad types of 
regulatory mechanisms. The first involves proteins that bind 
to target DNA sequences close to the initiation site (the core 
promoter elements) and are intimately associated with the 
mechanics of RNA initiation and elongation. The second set 
of regulators involves proteins that interact with DNA sites 
sometimes at considerable distances from the initiation site 
and restrict or stimulate transcription of the gene in certain 
cell types (enhancer and silencer elements). Recent investi- 
gations of the core promoter of the MBP gene have identified 
a number of target sites for transacting proteins within a few 
hundred bp of the initiation sites for transcription.  These 
sites have been shown to be important in the initiation of in 
vitro transcription by extracts of HeLa cells, mouse brain, 
and mouse liver, or in vivo in cultured cells transfected with 
MBP promoter fusion genes. While it is clear that these se- 
quences play a role in transcription, their participation in the 
events that restrict expression of the MBP gene to oligoden- 
drocytes and Schwann cells is obscure since the experimen- 
tal systems used to identify and define them (HeLa, hamster 
glial cell lines, NG 108-15 cells) normally do not express the 
MBP  gene.  An  important  difference between  transfected 
genes and the endogenous gene may be that the former were 
amplified in E. coli immediately before testing, while the en- 
dogenous genes, on the other hand, have traversed all of the 
developmental and differentiation  processes witnessed by the 
eukaryotic test cell.  It is  conceivable that post-replicative 
events and chromatin structure are important in conferring 
cell specificity to the transcription machinery of the cell. 
The transgenic mouse paradigm allows for a definitive study 
of the genetic elements conferring cell specificity for tran- 
scription,  since  not only has  the test DNA  traversed the 
developmental and differentiation programs,  it is also pre- 
sented in all cells of the organism and, therefore, represents 
a very stringent test of the specificity of gene expression. 
In  the present  communication we demonstrate that  the 
genetic elements conferring oligodendrocyte specific gene 
expression reside in the  1,943-bp sequence lying between 
position +36 and -1907 of the MBP gene. The MBP exons, 
introns and 3' sequences are not required for strict specificity. 
The 1,943-bp promoter/enhancer sequences also confer the 
correct temporal expression of reporter genes,  indicating 
that the genetic elements responsible for these changes are 
also present there. Surprisingly, the DNA elements confer- 
ring this exquisite control of expression in the oligodendro- 
cytes were not sufficient to specify expression in the other 
cell which normally expresses the MBP gene, the Schwann 
cell. Expression of MBP transgene could not be detected in 
peripheral nerve by either of the very sensitive assays used, 
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absence of expression in the Schwann cell may not be abso- 
lute and some expression below that detectable by our meth- 
ods may be suggested by other experiments. In experiments 
to be reported elsewhere (Peterson, A., S. Chang, H. Arn- 
heiter, R. Lazzarini, A. Bernstein, and M. Brieitman, per- 
sonal communication) we created transgenic mice carrying 
an attenuated diphtheria toxin gene controlled by a 6.5-kb 
DNA fragment containing the MBP promoter/enhancer. The 
transgenic mice had a shiverer phenotype as anticipated, and 
suffered from a striking deficiency in oligodendrocytes. Most 
of the myelin fibers in the PNS exhibited unremarkable fea- 
tures. However,  some perturbations of the PNS were noted, 
in particular,  some large  axons were ensheathed but not 
myelinated and occasional phagocytosing cells were encoun- 
tered, suggesting myelin and Schwann cell losses. These re- 
suits suggest very limited transgene expression in the PNS. 
These results, together with those reported herein, suggest 
that discrete additional cis-acting elements are required for 
copious  Schwann cell expression.  The very low  level  of 
Schwann cell expression in the absence of the Schwann cell- 
specific elements might be adventitious. 
The notion that oligodendrocyte-specific promoter  ele- 
ments might adventitiously stimulate low level expression in 
Schwann cells predicts  that endogenous genes which are 
putatively  oligodendrocyte-specific will  exhibit  some  ex- 
pression in Schwann cells. The recent demonstration that the 
PLP  gene,  previously  thought  to  be  expressed  only  in 
oligodendrocytes, is also expressed at low levels in Schwann 
cells may provide an example of low level, adventitious ex- 
pression in the PNS by a "CNS-specific" gene (1, 37). Unlike 
the other structural myelin proteins (MBP and MAG) that are 
expressed in both Schwann cells and oligodendrocytes, the 
PLP is not preferentially incorporated into compact PNS 
myelin, perhaps because it is not acylated in Schwann cells 
as it is in oligodendrocytes (1). Thus it is without known 
function in the Schwann cell. In this regard it would be in- 
teresting to ascertain whether shiverer mice, which carry a 
deletion in the MBP gene removing sequences 3' to the mid- 
dle of intron 2 (35, 43), express any MBP-derived transcripts 
in the PNS. The absence of shiverer MBP transcripts in the 
PNS would signal that sequences in the deleted portion of  the 
gene are important for expression in Schwann cells. 
The clear specificity in expression that we observe with the 
MBP-Lac Z transgene is in sharp contrast to the broad pat- 
tern of expression reported for MBP-MHC-1 antigen trans- 
genes (53, 56). The latter transgenes were expressed in lung, 
liver, testes, and intestinal villi, in addition to oligodendro- 
cytes. It seems unlikely that this difference is caused by the 
amount of MBP gene used as the promoter/enhancer (1.9 kb 
in our transgene,  1.3 kb in the MHC-1  transgenes) since 
other transgenes employing the 1.3-kb MBP sequence were 
not expressed in liver (25). However, a major difference be- 
tween the MHC-1  and the Lac Z transgenes is the presence 
of intronic sequences in the former which may contain en- 
hancer elements as in immunoglobulin (17, 19, 38), ~-globin 
(2,  4,  32)  or PDGF  (13).  Conceivably these elements, if 
present,  might  contribute  significantly to  the  pattern  of 
transgene expression.  On the other hand, we show in the 
present communication that two different transgenes, M/3P 
and MBG, with introns, splice and polyadenylation signals 
derived from two different genes (PLP and ~-globin genes, 
respectively) are expressed only in oligodendrocytes. These 
results argue strongly that the specificity we observe is con- 
ferred by the MBP promoter/enhancer and any PLP or/3-glo- 
bin derived enhancer elements contribute minimally to the 
pattern of expression. 
Another feature of  the MBP promoter sequence used in the 
present study that bears comment is its high efficiency of 
transcription. Although the steady state level of transgene 
mRNA was of the order of 1% that of the mRNA, nuclear 
run-on experiments showed that nascent transcripts of the 
transgene were synthesized at ,x,20-40%  the rate of MBP 
transcripts. The apparent discrepancy between the two types 
of measurements suggests that the transgene mRNA has a 
shorter  half life  than  most  MBP  mRNAs  in  this  cell. 
Presently, we do not have any information on the origin of 
this more rapid degradation or how it compares to the rates 
of turnover of other prokaryotic mRNA sequences in eukary- 
otic ceils. Nevertheless, the expectation is that the MBP pro- 
moter/enhancer described here has the potential to express 
genes fused to it at ~20-40% of the rate of MBP gene ex- 
pression. This rate of gene expression is close to that esti- 
mated by Kimura et al. (25) and Readhead et al. (41) for their 
transgenic lines which employed the 5' MBP promoter/en- 
hancer sequences. Of the six transgenlc lines tested by these 
two groups, four expressed in the 10 to 40% range. While 
there may be several explanations for the differences in tran- 
scription rate between the natural MBP gene and the trans- 
genes, two seem particularly noteworthy. First, the site of in- 
sertion of the transgene may have a profound effect on the 
transgene expression. The higher transcription rate of the 
natural MBP gene therefore might arise because it resides at 
a  site on chromosome 18 that is particularly conducive to 
transcription. Alternatively, the difference in the rates might 
result from the omission of an important part of the pro- 
moter/enhancer sequences in the transgenes. In this regard, 
the fact that the transgene promoter/enhancer is less efficient 
than the endogenous MBP gene is not totally unexpected 
since a binding site for a transcription factor was recently 
identified between position +25 and +45 of the MBP gene 
[48]. Since our promoter/enhancer fragment only extends to 
position +36, this site is incomplete in our transgenes. We 
are currently investigating this possibility and have generated 
mice (M'/3P) bearing transgenes that include MBP sequences 
to position +48, so that we might compare the efficiencies 
of transgene transcription in these new lines. 
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